Through purpose-driven science, empowering medicines, and transformative advocacy we seek to improve the lives of millions.

Our areas of focus

Uterine Fibroids

An estimated 5 million people in the U.S. suffer from symptoms of uterine fibroids.

Learn more »

Prostate Cancer

Approximately 3 million people alive today in the U.S. have been diagnosed with prostate cancer.

Learn more »

MYOVANT STORIES

Overcoming Stigma with Care and Community

Thomasine’s journey through uterine fibroids started with pain but led to empowerment.

Read Thomasine’s story

PURPOSE-DRIVEN SCIENCE

Myovant is developing innovative medicines that hold promise to improve people’s lives.

View our pipeline

TRANSFORMATIVE ADVOCACY

We’re partnering with cross-sector coalitions to fight stigma, raise awareness, and empower people with information.

Learn more

On Twitter

Tweets by Myovant

News

12 Oct 2021

Myovant Sciences to Host Second Fiscal Quarter 2021 Earnings Conference Call at 8:30 a.m. Eastern Time on October 26, 2021

9 Sep 2021

Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis

1 Sep 2021

Myovant Sciences to Participate in the 2021 Baird Global Healthcare Conference

12 Aug 2021

Myovant Sciences Appoints Uneek Mehra as Chief Financial and Business Officer

View more news

You are leaving www.myovant.com, a website provided by Myovant Sciences GmbH.
This link will take you to a different site.

Confirm Close